Literature DB >> 34554778

Reversible reprogramming of cardiomyocytes to a fetal state drives heart regeneration in mice.

Yanpu Chen1, Felipe F Lüttmann1, Eric Schoger2,3, Hans R Schöler4, Laura C Zelarayán2,3, Kee-Pyo Kim4,5, Jody J Haigh6,7, Johnny Kim1,8, Thomas Braun1,8.   

Abstract

Cardiomyocyte (CM) replacement is very slow in adult mammalian hearts, preventing regeneration of damaged myocardium. By contrast, fetal hearts display considerable regenerative potential owing to the presence of less mature CMs that still have the ability to proliferate. In this study, we demonstrate that heart-specific expression of Oct4, Sox2, Klf4, and c-Myc (OSKM) induces adult CMs to dedifferentiate, conferring regenerative capacity to adult hearts. Transient, CM-specific expression of OSKM extends the regenerative window for postnatal mouse hearts and induces a gene expression program in adult CMs that resembles that of fetal CMs. Extended expression of OSKM in CMs leads to cellular reprogramming and heart tumor formation. Short-term OSKM expression before and during myocardial infarction ameliorates myocardial damage and improves cardiac function, demonstrating that temporally controlled dedifferentiation and reprogramming enable cell cycle reentry of mammalian CMs and facilitate heart regeneration.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34554778     DOI: 10.1126/science.abg5159

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  20 in total

Review 1.  Heart regeneration: 20 years of progress and renewed optimism.

Authors:  Jessica C Garbern; Richard T Lee
Journal:  Dev Cell       Date:  2022-02-28       Impact factor: 12.270

2.  Report and Abstracts of the 18th Meeting of the Interuniversity Institute of Myology: Virtual meeting, October 21-24, 2021.

Authors:  Francesca Grassi; Sestina Falcone
Journal:  Eur J Transl Myol       Date:  2021-11-29

3.  Comparative transcriptomics reveals circadian and pluripotency networks as two pillars of longevity regulation.

Authors:  J Yuyang Lu; Matthew Simon; Yang Zhao; Julia Ablaeva; Nancy Corson; Yongwook Choi; KayLene Y H Yamada; Nicholas J Schork; Wendy R Hood; Geoffrey E Hill; Richard A Miller; Andrei Seluanov; Vera Gorbunova
Journal:  Cell Metab       Date:  2022-05-16       Impact factor: 31.373

Review 4.  Myocardial regeneration protocols towards the routine clinical scenario: An unseemly path from bench to bedside.

Authors:  Nadia Salerno; Luca Salerno; Fabiola Marino; Mariangela Scalise; Antonio Chiefalo; Giuseppe Panuccio; Antonella De Angelis; Eleonora Cianflone; Konrad Urbanek; Daniele Torella
Journal:  EClinicalMedicine       Date:  2022-06-27

Review 5.  The Art of Reprogramming for Regenerative Medicine.

Authors:  Junqi Kuang; Tao Huang; Duanqing Pei
Journal:  Front Cell Dev Biol       Date:  2022-06-30

Review 6.  The Cardiac Sarcomere and Cell Cycle.

Authors:  Anthony M Pettinato; Feria A Ladha; J Travis Hinson
Journal:  Curr Cardiol Rep       Date:  2022-04-05       Impact factor: 3.955

Review 7.  Forces in stem cells and cancer stem cells.

Authors:  Farhan Chowdhury; Bo Huang; Ning Wang
Journal:  Cells Dev       Date:  2022-03-26

8.  At the Brink of Human Therapy to Generate New Myocytes in the Adult Injured Heart.

Authors:  Vikram Prasad; Jeffery D Molkentin
Journal:  Circulation       Date:  2022-04-25       Impact factor: 39.918

Review 9.  Signaling cascades in the failing heart and emerging therapeutic strategies.

Authors:  Xin He; Tailai Du; Tianxin Long; Xinxue Liao; Yugang Dong; Zhan-Peng Huang
Journal:  Signal Transduct Target Ther       Date:  2022-04-23

Review 10.  Tailoring Cardiac Synthetic Transcriptional Modulation Towards Precision Medicine.

Authors:  Eric Schoger; Sara Lelek; Daniela Panáková; Laura Cecilia Zelarayán
Journal:  Front Cardiovasc Med       Date:  2022-01-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.